Open AccessDoes Trimethoprim-Sulfamethoxazole prophylaxis induce myelosuppression in primary immune deficiency disease patients; A retrospective, 3 groups comparative study
Author(s) -
Reem Elajez,
Sabha Nisar,
Mehdi Adeli
Publication year - 2023
Publication title -
asian pacific journal of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 33
ISSN - 0125-877X
DOI - 10.12932/ap-050320-0782
Subject(s) - medicine , gastroenterology , sulfamethoxazole , trimethoprim , retrospective cohort study , urinary system , platelet , immune system , antibiotics , immunology , microbiology and biotechnology , biology
The possible myelosuppression side effect of Trimethoprim-Sulfamethoxazole (TMP-SMX) on primary immune deficiency (PID) patients has not been established yet.